ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In a model of BCR-ABL driven chronic myeloid leukaemia (CML), persistent leukaemic stem cells (LSC) responsible for treatment resistance and relapse depended on OXPHOS upregulation for survival.